Nasdaq · Common stock
Kardigan (KARD)
$12.63 −$0.17 (−1.33%)
- Day’s range
- $12.60–$13.15
- Volume
- 216,097
KARD price history
KARD closed at $12.63 on Oct. 26, 2026. Over the past year, its daily close ranged from $12.63 on Oct. 26, 2026 to $25.90 on June 29, 2026.
Data table: KARD daily closes, the past year
| Date | Close |
|---|---|
| Oct. 26, 2026 | $12.63 |
| Oct. 23, 2026 | $12.80 |
| Oct. 22, 2026 | $12.74 |
| Oct. 21, 2026 | $12.85 |
| Oct. 20, 2026 | $13.51 |
| Oct. 19, 2026 | $12.94 |
| Oct. 16, 2026 | $13.03 |
| Oct. 15, 2026 | $13.88 |
| Oct. 14, 2026 | $13.52 |
| Oct. 13, 2026 | $12.97 |
| Oct. 12, 2026 | $14.35 |
| Oct. 9, 2026 | $14.67 |
| Oct. 8, 2026 | $14.20 |
| Oct. 7, 2026 | $13.83 |
| Oct. 6, 2026 | $13.49 |
| Oct. 5, 2026 | $15.24 |
| Oct. 2, 2026 | $14.79 |
| Oct. 1, 2026 | $14.25 |
| Sept. 30, 2026 | $14.75 |
| Sept. 29, 2026 | $14.66 |
| Sept. 28, 2026 | $14.78 |
| Sept. 25, 2026 | $14.79 |
| Sept. 24, 2026 | $14.39 |
| Sept. 23, 2026 | $14.52 |
| Sept. 22, 2026 | $16.44 |
| Sept. 21, 2026 | $16.30 |
| Sept. 18, 2026 | $16.64 |
| Sept. 17, 2026 | $16.69 |
| Sept. 16, 2026 | $17.31 |
| Sept. 15, 2026 | $18.56 |
| Sept. 14, 2026 | $19.05 |
| Sept. 11, 2026 | $18.52 |
| Sept. 10, 2026 | $18.69 |
| Sept. 9, 2026 | $19.68 |
| Sept. 8, 2026 | $21.60 |
| Sept. 4, 2026 | $20.85 |
| Sept. 3, 2026 | $20.74 |
| Sept. 2, 2026 | $21.92 |
| Sept. 1, 2026 | $19.60 |
| Aug. 31, 2026 | $20.16 |
| Aug. 28, 2026 | $20.02 |
| Aug. 27, 2026 | $20.80 |
| Aug. 26, 2026 | $21.18 |
| Aug. 25, 2026 | $20.92 |
| Aug. 24, 2026 | $20.64 |
| Aug. 21, 2026 | $21.02 |
| Aug. 20, 2026 | $20.26 |
| Aug. 19, 2026 | $22.01 |
| Aug. 18, 2026 | $20.92 |
| Aug. 17, 2026 | $20.55 |
| Aug. 14, 2026 | $20.20 |
| Aug. 13, 2026 | $21.81 |
| Aug. 12, 2026 | $21.78 |
| Aug. 11, 2026 | $22.06 |
| Aug. 10, 2026 | $21.08 |
| Aug. 7, 2026 | $20.50 |
| Aug. 6, 2026 | $20.36 |
| Aug. 5, 2026 | $20.25 |
| Aug. 4, 2026 | $20.49 |
| Aug. 3, 2026 | $19.97 |
| July 31, 2026 | $20.82 |
| July 30, 2026 | $20.47 |
| July 29, 2026 | $19.73 |
| July 28, 2026 | $20.99 |
| July 27, 2026 | $21.23 |
| July 24, 2026 | $20.74 |
| July 23, 2026 | $21.67 |
| July 22, 2026 | $22.86 |
| July 21, 2026 | $22.91 |
| July 20, 2026 | $21.40 |
| July 17, 2026 | $21.13 |
| July 16, 2026 | $21.02 |
| July 15, 2026 | $21.99 |
| July 14, 2026 | $22.26 |
| July 13, 2026 | $23.53 |
| July 10, 2026 | $24.64 |
| July 9, 2026 | $24.45 |
| July 8, 2026 | $22.22 |
| July 7, 2026 | $23.83 |
| July 6, 2026 | $23.78 |
| July 2, 2026 | $24.35 |
| July 1, 2026 | $24.11 |
| June 30, 2026 | $23.85 |
| June 29, 2026 | $25.90 |
| June 26, 2026 | $23.60 |
| June 25, 2026 | $22.58 |
| June 24, 2026 | $22.03 |
| June 23, 2026 | $22.24 |
| June 22, 2026 | $22.77 |
| June 18, 2026 | $22.00 |
Key figures
- Average daily volume
- 544,082Past 3 months
- Market value
- $1.18B
- Dividend yield
- —
Price change
- 1 month
- −14.60%
- 3 months
- −39.10%
What Wall Street says about KARD
In the past 90 days, Wall Street firms published 4 rating or price-target actions on KARD: 3 new ratings and 1 lowered price target.
| Action | Rating | |||
|---|---|---|---|---|
| Baird | Initiates coverage | Outperform | $43 | |
| William Blair | Initiates coverage | Outperform | — | |
| UBS | Initiates coverage | Buy | $25 | |
| JP Morgan | Cuts target | Overweight | $51 to $46 |
Ratings and price targets are the firms’ own opinions, reported as published.
Not investment advice.
About Kardigan, Inc. Common Stock
Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.
- Headquarters
- South San Francisco, Calif.
- Listed
- June 18, 2026
- Sector
- Health care
- Industry
- Pharmaceutical preparations
In WallStreetDigest editions
No WallStreetDigest article about KARD is on the site yet.